Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zogenix Inc (NASDAQ:ZGNX)

35.15
Delayed Data
As of Jan 16
 -2.45 / -6.52%
Today’s Change
7.70
Today|||52-Week Range
43.35
-12.23%
Year-to-Date
No recent news for Zogenix Inc.

Today’s Trading

Previous close37.60
Today’s open37.60
Day’s range34.67 - 37.95
Volume1,422,011
Average volume (3 months)1,440,715
Market cap$1.2B
Data as of 4:00pm ET, 01/16/2018

Growth & Valuation

Earnings growth (last year)-22.42%
Earnings growth (this year)-50.43%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+4.22%
P/E ratioNM
Price/Sales10.44
Price/Book7.73

Competitors

 Today’s
change
Today’s
% change
IDRAIdera Pharmaceutical...-0.08-3.21%
COLLCollegium Pharmaceut...+1.11+5.54%
CORICorium International...+0.10+0.84%
URGNUrogen Pharma Ltd+0.89+2.02%
Data as of 4:00pm ET, 01/16/2018

Financials

Next reporting dateMarch 8, 2018
EPS forecast (this quarter)-$0.94
Annual revenue (last year)$28.9M
Annual profit (last year)-$69.7M
Net profit margin-238.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Stephen J. Farr
CFO, Secretary, Treasurer &
Executive VP
Michael P. Smith
Corporate headquarters
Emeryville, California

Forecasts